- Nordic Nanovector board member resigns
- Nordic Nanovector ASA: Extraordinary General Meeting held
- Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 3 January 2023
- Nordic Nanovector update following shareholder vote against proposed merger with APIM Therapeutics
- Nordic Nanovector Launches Dedicated Area on its Website in Norwegian for Information on the Proposed Merger with APIM Therapeutics
- Nordic Nanovector: Invitation to webcast regarding proposed merger with APIM Therapeutics
- Nordic Nanovector comment on Proposed Merger with APIM Therapeutics
- Nordic Nanovector ASA - Notice of Extraordinary General Meeting on 1 December 2022
- Nordic Nanovector and APIM Therapeutics Announce Merger Agreement
- Nordic Nanovector Highlights Novel Humanized Anti-CD37 Therapeutic Antibody Candidates for B-cell Malignancies or B-cell-driven Autoimmune Disorders at ASH Annual Meeting
Nordic Nanovector ASA (0R6Y:LSE) closed at 1.01, 9.97% above its 52-week low of 0.9175, set on Nov 29, 2022.
0.9175Nov 29 202215.44Mar 28 2022
Markit short selling activity
|Market cap||116.04m NOK|
|EPS (TTM)||-4.20 |
Data delayed at least 20 minutes, as of Jan 06 2023 15:42 GMT.